Croft, James
Ellis, Sidra
Sherborne, Amy L.
Sharp, Kim
Price, Amy
Jenner, Matthew W.
Drayson, Mark T. http://orcid.org/0000-0002-1528-7564
Owen, Roger G.
Chown, Sally
Lindsay, Jindriska
Karunanithi, Kamaraj http://orcid.org/0000-0002-4708-8092
Hunter, Hannah
Gregory, Walter M. http://orcid.org/0000-0003-2641-8416
Davies, Faith E.
Morgan, Gareth J.
Cook, Gordon http://orcid.org/0000-0003-1717-0412
Atanesyan, Lilit
Savola, Suvi
Cairns, David A. http://orcid.org/0000-0002-2338-0179
Jackson, Graham
Houlston, Richard S. http://orcid.org/0000-0002-5268-0242
Kaiser, Martin F. http://orcid.org/0000-0002-3677-4804
Funding for this research was provided by:
Celgene (Educational grant)
Myeloma UK
Myeloma UK: MUK-CTR David Forbes-Nixon Foundation: Jacquelin Forbes-Nixon Fellowship NIHR Biomedical Research Centre at Institute of Cancer Research and Royal Marsden Hospital
Article History
Received: 30 June 2020
Revised: 2 October 2020
Accepted: 14 November 2020
First Online: 1 December 2020
Compliance with ethical standards
:
: MWJ: Janssen—consultancy, honoraria, travel support, research funding; Takeda—consultancy, honoraria, travel support; Amgen—consultancy, honoraria, travel support; Celgene Corporation—consultancy, honoraria, research funding; Novartis—consultancy, honoraria. MTD: Abingdon Health—equity ownership, membership on an entity’s board of directors or advisory committees. RGO: Takeda—honoraria, travel support; Janssen—consultancy, travel support; Celgene Corporation—consultancy, honoraria, research funding. JL: Janssen—consultancy; Novartis—travel support; Takeda—honoraria, travel support; Bristol-Myers Squibb—consultancy, travel support; Celgene Corporation—consultancy, honoraria, travel support. KK: Celgene Corporation—travel support, research funding; Janssen—travel support, research funding. WMG: Celgene Corporation—consultancy, research funding; Amgen, Merck Sharp and Dohme—research funding; Janssen—honoraria. FED: Amgen—consultancy, honoraria; AbbVie—consultancy, honoraria; Takeda—consultancy, honoraria; Janssen—consultancy, honoraria; Celgene Corporation—consultancy, honoraria, research funding; Roche—consultancy, honoraria. GJM: Janssen—research funding; Bristol-Myers Squibb—consultancy, honoraria; Takeda—consultancy, honoraria; Celgene Corporation—consultancy, honoraria, research funding; Roche—consultancy, honoraria; Amgen—consultancy, honoraria; GSK—consultancy, honoraria; Karyopharm—consultancy, honoraria. GC: Takeda—consultancy, honoraria, research funding, speakers bureau; Glycomimetics—consultancy, honoraria; Sanofi—consultancy, honoraria, speakers bureau; Celgene Corporation—consultancy, honoraria, research funding, speakers bureau; Janssen—consultancy, honoraria, research funding, speakers bureau; Bristol-Myers Squibb—consultancy, honoraria; Amgen—consultancy, honoraria, research funding, speakers bureau. LA: MRC-Holland—employment. SS: MRC-Holland—employment. DAC: Celgene Corporation, Amgen, Merck Sharp and Dohme—research funding. GHJ: Roche—consultancy, honoraria, speakers bureau; Amgen—consultancy, honoraria, speakers bureau; Janssen—consultancy, honoraria, speakers bureau; Merck Sharp and Dohme—consultancy, honoraria, speakers bureau; Celgene Corporation—consultancy, honoraria, travel support, research funding, speakers bureau; Takeda—consultancy, honoraria, travel support, research funding, speakers bureau. MFK: AbbVie—consultancy; Bristol-Myers Squibb—consultancy, travel support; Chugai—consultancy; GSK—consultancy; Janssen—consultancy, honoraria, research funding; Amgen—consultancy, honoraria; Takeda—consultancy, travel support; Celgene Corporation—consultancy, honoraria, and research funding.